Key personnel

Introduction to the pathway group

Skin cancer is increasing across all age groups. Despite this, it is managed in different ways in London depending on who the patient is referred to. At present GPs can refer to GPs with Special Interest (GPwSI), dermatologists, plastic surgeons or radiotherapists. A small number are referred to oncologists or general surgeons.

The LCA skin pathway group aims to improve patient access, experience and outcomes for skin cancer patients within south and west London. It will allow the opportunity to ensure that patients are referred following designated pathways, ensuring equity of care.

The membership of the group brings together specialist expertise from primary, secondary and tertiary care as well as patients and users to enable development of high quality patient centred care.

The skin cancer pathway group supports the aims and objectives of the LCA in providing world class cancer services across south and west London. It aims to improve cancer patients' experience and outcomes through delivering excellence in clinical care, research, innovation and education with particular emphasis on earlier diagnosis for skin cancer. You can read the group's terms of reference here.

It has been agreed that those with low risk skin cancers may not need a full holistic needs assessment (HNA). As a result, the skin cancer pathway groups of the LCA and London Cancer have developed an HNA screening tool specifically for those with low risk skin cancers. All others, or those with low risk skin cancer who identify a high level of distress, should have the opportunity to have a full HNA. The Pan-London skin HNA is available here.


  • To set standards and accreditation criteria as appropriate to ensure a standardised, high quality, patient centered  approach to the management of skin cancer across all providers within the LCA.
  • To develop and agree metrics that demonstrate quality and outcomes.
  • Review and improve service provision and access, and to standardise approaches to service delivery where appropriate.
  • Define and implement plans to improve patient experience and patient information.
  • Ensure systems are in place for patients to be offered a holistic needs assessment (HNA), access to psychological support and provision of treatment summaries.
  • Establish systems for monitoring peer review, clinical lines of inquiry, quality standards and outcome measures and, where these are not achieved, agree a process of corrective measures.  
  • Establish a trials portfolio and develop plans to encourage and increase participation of units in local research and national clinical trials.
  • Compliance against Improving Outcomes Guidance.
  • Develop a response to the Model of Care.
  • Develop equity and uniformity of services to include radiotherapy across the LCA
  • Achieve 100% data entry and work with Thames Cancer Registry and multidisciplinary teams to improve staging data returns of newly diagnosed cancers


  • Provision of combined clinics across the LCA delivering optimal diagnostics and treatment.
  • Equal access to services for all patients, for example, trials, radiotherapy technologies, and specialty surgery.
  • Follow-up and molecular testing of high risk melanoma patients. Early detection of melanomas can offer effective drug regimes that are NICE approved. Small volume disease responds better to these drugs.
  • Establish an LCA research database and develop strong research collaboration across the LCA.
  • Produce patient information for melanoma and sentinel node biopsy (SLNB) to help patients in their treatment decision making
  • Define and develop primary care education packages to improve the quality of referrals, awareness and diagnosis of skin cancer.
  • Develop a GP-led service model in the management of primary care skin lesions.


  • Development and implementation of a comprehensive and seamless exemplar skin pathway across the LCA based upon national and international standards, research and evidence.
  • Deliver the recommendations in the Model of Care.
  • Improve cancer patients' experience and outcomes through delivering excellence in clinical care, research, innovation and education.
  • To improve care and ensure equitable access to specialists, GPs, hospitals, radiotherapy and healthcare professionals thus improving the outcomes of the population of London the LCA
  • Earlier detection, diagnosis and treatment of skin cancers



Close ×